Cargando…
De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist
Lasso-grafting (LG) technology is a method for generating de novo biologics (neobiologics) by genetically implanting macrocyclic peptide pharmacophores, which are selected in vitro against a protein of interest, into loops of arbitrary protein scaffolds. In this study, we have generated a neo-capsid...
Autores principales: | Komatsu, Yamato, Terasaka, Naohiro, Sakai, Katsuya, Mihara, Emiko, Wakabayashi, Risa, Matsumoto, Kunio, Hilvert, Donald, Takagi, Junichi, Suga, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581506/ https://www.ncbi.nlm.nih.gov/pubmed/34805784 http://dx.doi.org/10.1016/j.isci.2021.103302 |
Ejemplares similares
-
Lasso-grafting of macrocyclic peptide pharmacophores yields multi-functional proteins
por: Mihara, Emiko, et al.
Publicado: (2021) -
Designing receptor agonists with enhanced pharmacokinetics by grafting macrocyclic peptides into fragment crystallizable regions
por: Sakai, Katsuya, et al.
Publicado: (2022) -
Cellular signaling and gene expression profiles evoked by a bivalent macrocyclic peptide that serves as an artificial MET receptor agonist
por: Miao, Wenyu, et al.
Publicado: (2018) -
Probing conformational and functional states of human hepatocyte growth factor by a panel of monoclonal antibodies
por: Umitsu, Masataka, et al.
Publicado: (2016) -
Artificial human Met agonists based on macrocycle scaffolds
por: Ito, Kenichiro, et al.
Publicado: (2015)